HONG KONG, Sep 1, 2026 – (ACN Newswire) –Foundation Robotics, an ingenious surgical robotics business established and headquartered in Hong Kong, today revealed a tactical collaboration with Medtronic (NYSE: MDT), a worldwide leader in health care innovation. As part of the collaboration, Medtronic will make an around US$ 700 million tactical financial investment in Cornerstone Robotics and have rights to disperse Cornerstone Robotics’ SentireTM surgical system in choose markets outside the U.S. where the system is market authorized.
A Shared Vision: Bridging the Global Access Gap in Minimally Invasive Care
With robotic-assisted surgical treatment adoption still in single digits internationally, the chance to make innovative surgical care available to more clients, doctors, and health systems around the globe is considerable.
Resolving this market needs both constant technical development and strong market scaling abilities. By lining up Cornerstone Robotics’ innovation with Medtronic’s detailed worldwide existence, the 2 business intend to make premium robotic-assisted surgical treatment available to more clients worldwide.
A Strategic Alignment: Scaling Technology Solutions to Reach More Patients
Foundation Robotics has actually developed a strong tactical structure through its full-stack internal R&D and vertically incorporated paradigm. By individually establishing its core hardware, control software application, advanced algorithms, and exclusive imaging and energy platforms, Cornerstone Robotics preserves considerable control over item combination, quality, and supply chain strength. This underpins the extraordinary stability and high-fidelity efficiency of the Sentire surgical system in requiring medical environments.
In 2024, Cornerstone Robotics’ Sentire surgical system got National Medical Products Administration approval in China. In May 2026, Sentire surgical system got CE Mark in the European Union and approval from Singapore Health Sciences Authority, both covering minimally intrusive basic, gynecologic, thoracic, and urologic surgeries.
“This collaboration marks a crucial action in advancing access to robotic-assisted surgical treatment around the globe,” stated Professor Kwok Wai Samuel AU, Founder and CEO of Cornerstone Robotics. “There stays a considerable space in between the growing need for minimally intrusive surgical treatment and the schedule of robotic-assisted surgical innovations. At Cornerstone Robotics, we have actually developed a strong structure through full-stack internal R&D and vertical combination, allowing us to continually advance the core innovations of surgical robotics. Our collaboration with Medtronic positions us to additional speed up and scale our work to bring the advantages of robotic-assisted surgical treatment to more cosmetic surgeons and clients worldwide.”
“This financial investment and circulation contract reinforces Medtronic’s capability to even more broaden access to minimally intrusive surgical treatment to more clients around the globe. We’re thrilled to bring more option in robotics, and Sentire is a strong enhance to our Hugo platform,” stated Matt Anderson, Senior Vice President and President, Surgical at Medtronic.
The collaboration marks a substantial turning point for both business to collaboratively advance their shared objective of making robotic-assisted surgical treatment more available around the world.
Advisors
Kirkland & & Ellis and Global Law Office are serving as legal counsel to Cornerstone Robotics. Morgan Stanley & & Co. LLC is acting as unique monetary consultant to Medtronic, and Cleary Gottlieb Steen & & Hamilton LLP is working as lead legal counsel.
About Cornerstone Robotics
Established and headquartered in Hong Kong, Cornerstone Robotics is an ingenious surgical robotics business driven by the vision of leading medical developments for a much healthier world. We advance surgical care with innovative robotic systems that make premium health care more available and effective worldwide. With 3 international R&D centers and 6 service centres worldwide, Cornerstone Robotics has actually developed a 30,000-square-meter production center in China. Established totally internal, our SentireTM surgical system has actually finished multi-specialty medical trials and got market approval throughout China, the European Union and Singapore, advancing premium surgical care worldwide.
To learn more details, please check out https://en.csrbtx.com/ and follow us on LinkedIn.
About Medtronic
Strong thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading worldwide health care innovation business that boldly assaults the most tough health issue dealing with humankind by locating and discovering services. Our Mission– to minimize discomfort, bring back health, and extend life– unifies a worldwide group of 95,000+ enthusiastic individuals throughout more than 150 nations. Our innovations and treatments deal with 70 health conditions and consist of heart gadgets, surgical robotics, insulin pumps, surgical tools, client tracking systems, and more. Powered by our varied understanding, pressing interest, and desire to assist all those who require it, we provide ingenious innovations that change the lives of 2 individuals every 2nd, every hour, every day. Anticipate more from us as we empower insight-driven care, experiences that put individuals initially, and much better results for our world. In whatever we do, we are crafting the remarkable. To find out more on Medtronic, go to www.Medtronic.com and follow on LinkedIn.
Subject: Press release summary